OBGYN & Reproduction Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of OBGYN & Reproduction Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Gynecology
TVS doesn't aid diagnosis of endometrial pathology in women taking tamoxifen
July 4th, 2005
Radiologists at the Birmingham Women's Hospital, U.K., say positive transvaginal ultrasound results aren't useful in the diagnosis of endometrial pathology in postmenopausal women taking tamoxifen. According to J. Weaver and colleagues, "The incidence of endometrial pathology is increased in women with tamoxifen-induced postmenopausal bleeding (PMB). The aim of this study was to determine the accuracy of transvaginal ultrasound (TVS) in diagnosing endometrial pathology in symptomatic women taking tamoxifen, using endometrial thickness measurements (5-mm and 10-mm cut-offs) and morphological changes within the uterine cavity to define abnormality." ...
Source: OBGYN & Reproduction Week (2005-07-04)
|
